Financials

  • Market Capitalization 395.23 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.12
Relación precio/flujo de caja
0

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3075
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.06 USD-4.02%0.00%+3.31%+36.70%402.54 M USD
3076
CTNM
Contineum Therapeutics, Inc. - Common stock
17.39 USD+0.81%+1.28%+22.72%+13.88%401.69 M USD
3092
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.80 USD-3.81%-2.24%+9.34%-0.21%393.82 M USD
3109
EYPT
EyePoint, Inc. - Common Stock
4.47 USD-3.46%-12.52%-62.69%-62.75%385.37 M USD

Noticias